These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6673031)

  • 41. Changes in blood filterability in cerebrovascular accidents.
    Boisseau MR; Freyburger G; Lorient-Roudaut MF
    Wien Med Wochenschr; 1986; 136 Spec No():44-6. PubMed ID: 3825170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome.
    Keenan EJ; Porter JM
    Surgery; 1983 Aug; 94(2):204-9. PubMed ID: 6308842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [CRST syndrome (calcinosis cutis--Raynaud's phenomenon--sclerodactylia--telangiectasis)].
    Ohm OJ
    Nord Med; 1970 Feb; 83(9):268-70. PubMed ID: 5426404
    [No Abstract]   [Full Text] [Related]  

  • 44. Elevated homocysteine levels in patients with Raynaud's syndrome.
    Levy Y; George J; Langevitz P; Harats D; Doolman R; Sela BA; Shoenfeld Y
    J Rheumatol; 1999 Nov; 26(11):2383-5. PubMed ID: 10555896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemorheological mechanisms in Alzheimer's disease.
    Chang CY; Liang HJ; Chow SY; Chen SM; Liu DZ
    Microcirculation; 2007 Aug; 14(6):627-34. PubMed ID: 17710633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidant/antioxidant status in patients with Raynaud's disease.
    Biondi R; Coaccioli S; Lattanzi S; Puxeddu A; Papini M
    Clin Ter; 2008; 159(2):77-81. PubMed ID: 18463765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon.
    Kallenberg CG; Vellenga E; Wouda AA; The TH
    J Rheumatol; 1982; 9(6):878-84. PubMed ID: 7161779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hemorheological, hemocoagulation and photoplethysmographic changes induced by the administration of pentoxifylline in patients with Raynaud's disease].
    Macchione C; Molaschi M; Neirotti M; Garrone MT; Longo F; Pernigotti L
    Minerva Med; 1985 Jul; 76(30-31):1401-5. PubMed ID: 4022431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo study of skin mechanical properties in Raynaud's phenomenon.
    Dobrev H
    Skin Res Technol; 2007 Feb; 13(1):91-4. PubMed ID: 17250538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Rheologic properties of the blood in Raynaud's syndrome and disease].
    Kovalenko VI; Baturin LI
    Vestn Khir Im I I Grek; 1983 Aug; 131(8):37-9. PubMed ID: 6649277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal blood viscosity in Raynaud's phenomenon.
    Goyle KB; Dormandy JA
    Lancet; 1976 Jun; 1(7973):1317-8. PubMed ID: 58309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The natural course of Raynaud's phenomenon].
    Clavijo F; Krahenbuhl B
    Schweiz Med Wochenschr; 1981 Dec; 111(51):2023-7. PubMed ID: 7313657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
    Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N
    Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Incomplete Raynaud's syndrome with extensive osteolysis, acrosclerosis, multiple visceral lesions. Systemic scleroderma].
    Michel PJ; Frieh P; Cretin J; Cassin B
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):526-31. PubMed ID: 5585213
    [No Abstract]   [Full Text] [Related]  

  • 60. BLOOD VISCOSITY AND RAYNAUD'S DISEASE.
    PRINGLE R; WALDER DN; WEAVER JP
    Lancet; 1965 May; 1(7395):1086-8. PubMed ID: 14289442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.